Merck KGaA to pay over $3M to patients after drug formulation change-up triggered complaints

Ending a five-year saga, France’s highest court has ordered Merck KGaA to pay out more than $3.6 million to more than 3,000 patients to settle a long-running dispute over the reformulation of one of its drugs.